Tirzepatide, a dual GIP/GLP-1 receptor co-agonist, may induce a specific microbial footprint that differs from pure GLP-1 agonism, as GIP signaling independently participates in lipid handling and mucosal immune regulation, potentially modifying the nutrient-delivery profile to the gut (54)
R., Gould, R
Theres a grain of truth to this argument: archaeological and genetic evidence suggests that early modern humans ate a fatty , protein-rich diet shortly before the advent of carbohydrate-rich agriculture [19, 20, 21, 22]
Cell culture studies In laboratory studies using 3T3-L1 adipocytes, a commonly used fat cell line, researchers found that 5-amino-1mq significantly reduced intracellular levels of 1-methylnicotinamide, confirming that it was successfully inhibiting NNMT
However, if these symptoms persist for a long time, a doctor should be contacted